Xim Limited
7
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Role: lead
Lifelight Non-Invasive Blood Pressure and Heart Rate Validation Study
Role: lead
The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care
Role: lead
The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development
Role: lead
The VISION-Acute Study
Role: lead
Vital Sign Comparison Between Lifelight and Standard of Care - Development
Role: lead
A Single Center Study to Demonstrate the Safety and Performance of Lifelight® First Software Application
Role: lead
All 7 trials loaded